Αποτελέσματα Αναζήτησης
8 Απρ 2022 · The effectiveness against infection of COVID-19 vaccines waned considerably 5–8 months after primary vaccination, although it remained high, particularly among people younger than 55 years. Vaccine boosters were effective in restoring protection against infection and had a good safety profile in the community.
26 Φεβ 2024 · The study, published in Vaccine, confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).1
25 Ιαν 2023 · Bivalent boosters provided substantial additional protection against severe omicron infection in persons who had previously been vaccinated or boosted, although the effectiveness waned over...
10 Οκτ 2024 · COVID-19 mRNA booster vaccination implies a low prevalence of moderate-to-severe side-effects among PHCPs, with a short median duration of symptoms if any. The strongest predictors are a history of moderate-to-severe side-effects after any previous dose and being female.
26 Απρ 2021 · A few possible causes include: nose picking. foreign objects stuck in your nose. chemical irritation. allergies. cold air. upper respiratory infection. Researchers have established that the...
21 Μαρ 2022 · Typical side effects for all COVID-19 vaccines are mild and require little more than rest. Let's discuss how this can affect different ages and how to recover.
19 Απρ 2022 · The Pfizer-BioNTech vaccine (BNT162b2), which is approved for people age 16 and older and is authorized under emergency use for children and teens 5 to 15 years old. The Moderna vaccine (mRNA-1273), which is authorized under emergency use for people age 18 and older.
